Evaluation and Management of Elevated Liver Enzymes

Initial Evaluation

The American Gastroenterological Association recommends an initial follow-up for elevated liver enzymes that includes both laboratory tests to exclude common hepatic diseases and radiologic evaluation, with the specific approach determined by the pattern and degree of enzyme elevation 1, 2
History and physical examination should focus on risk factors for liver disease, medication use, alcohol consumption, comorbidities, and signs of hepatic disease 1, 3
Laboratory evaluation should include a complete blood count with platelets 4, hepatic panel (comprehensive metabolic panel) 1, 5, coagulation studies (prothrombin time) 4, tests for viral hepatitis (HAV-IgM, HBsAg, HBcIgM, HCV antibody) 1, 5, tests for autoimmune liver disease (immunoglobulins, autoantibodies) 6, and iron studies (ferritin, transferrin saturation) to evaluate for hemochromatosis 6
Radiologic evaluation should include abdominal ultrasonography as the primary imaging modality 1, 7, with more advanced imaging (CT or MRI) may be needed depending on clinical scenario 1, 8

For hepatocellular pattern (predominant ALT/AST elevation) with mild elevations (<5× ULN), serial monitoring of liver enzymes every 3-6 months is recommended 2, 4
For hepatocellular pattern with moderate to severe elevations (>5× ULN), a more expeditious and complete diagnostic evaluation is recommended 1, 3
For cholestatic pattern (predominant alkaline phosphatase/GGT elevation), determine if hyperbilirubinemia is conjugated (direct) or unconjugated (indirect) and evaluate for biliary obstruction with imaging (ultrasonography, MRCP, or ERCP) 1, 8

Patients with diabetes should be screened for non-alcoholic fatty liver disease (NAFLD) regardless of liver enzyme levels 7
Transient elastography (FibroScan) with controlled attenuation parameter (CAP) may be useful for quantifying steatosis and fibrosis in patients with NAFLD 7
Consider liver biopsy after 6 months of unexplained elevation despite appropriate workup 1, 8

For mild, unexplained elevations, repeat liver enzymes every 3-6 months 2, 4
For identified liver disease, follow-up intervals and testing should be disease-specific 1, 3
Monitor for disease progression and treatment response, and screen for hepatocellular carcinoma in high-risk populations with chronic liver disease 4

Failure to recognize that normal liver enzymes do not exclude significant liver disease 5
Focusing solely on liver enzymes without considering synthetic function (albumin, prothrombin time) 4
Neglecting to screen for hepatocellular carcinoma in high-risk populations with chronic liver disease 4